{"entity":{"type":"insider","cik":"0001789042","url":"/insider/0001789042","json_url":"/insider/0001789042.json","name":"Seizinger Bernd R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2022-05-19","last":"2026-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Seizinger Bernd R.","source":"filing","n_filings":7,"first_seen":"2022-05-19","last_seen":"2026-02-13"}],"transactions":[{"id":5946908,"accession":"0001493152-26-006548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-26-006548","line_url":"/filing/0001493152-26-006548#line-2","is_derivative":false,"issuer_cik":"0001129928","issuer_name":"ONCOLYTICS BIOTECH INC","issuer_ticker":"ONCY","issuer_name_source":null,"issuer_url":"/issuer/0001129928","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":0.8466,"price_display":"0.85","price_state":"stated","total_value":33864.0,"total_display":"33,864.00","total_whole":"33,864","shares_owned_after":566991.0,"shares_owned_after_display":"566,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-13","scope":"insider"},{"id":5946906,"accession":"0001493152-26-006548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-006548","line_url":"/filing/0001493152-26-006548#line-1","is_derivative":false,"issuer_cik":"0001129928","issuer_name":"ONCOLYTICS BIOTECH INC","issuer_ticker":"ONCY","issuer_name_source":null,"issuer_url":"/issuer/0001129928","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":0.8265,"price_display":"0.83","price_state":"stated","total_value":49590.0,"total_display":"49,590.00","total_whole":"49,590","shares_owned_after":526991.0,"shares_owned_after_display":"526,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-13","scope":"insider"},{"id":5871339,"accession":"0001493152-26-002879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-002879","line_url":"/filing/0001493152-26-002879#line-1","is_derivative":false,"issuer_cik":"0001129928","issuer_name":"ONCOLYTICS BIOTECH INC","issuer_ticker":"ONCY","issuer_name_source":null,"issuer_url":"/issuer/0001129928","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.0377,"price_display":"1.04","price_state":"stated","total_value":103770.0,"total_display":"103,770.00","total_whole":"103,770","shares_owned_after":466991.0,"shares_owned_after_display":"466,991","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":2600820,"accession":"0001104659-24-108377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-108377","line_url":"/filing/0001104659-24-108377#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.68,"price_display":"2.68","price_state":"stated","total_value":26800.0,"total_display":"26,800.00","total_whole":"26,800","shares_owned_after":44730.0,"shares_owned_after_display":"44,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-15","scope":"insider"},{"id":2656506,"accession":"0001104659-24-034672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-034672","line_url":"/filing/0001104659-24-034672#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6860.0,"shares_display":"6,860","price_per_share":7.29,"price_display":"7.29","price_state":"stated","total_value":50009.4,"total_display":"50,009.40","total_whole":"50,009","shares_owned_after":33685.0,"shares_owned_after_display":"33,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-14","scope":"insider"},{"id":8721300,"accession":"0000912282-23-000385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000912282-23-000385","line_url":"/filing/0000912282-23-000385#line-1","is_derivative":false,"issuer_cik":"0000882361","issuer_name":"Aptose Biosciences Inc.","issuer_ticker":"APTO","issuer_name_source":null,"issuer_url":"/issuer/0000882361","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":3.14,"price_display":"3.14","price_state":"stated","total_value":53380.0,"total_display":"53,380.00","total_whole":"53,380","shares_owned_after":17000.0,"shares_owned_after_display":"17,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-25","scope":"insider"},{"id":8622927,"accession":"0001104659-23-069421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-069421","line_url":"/filing/0001104659-23-069421#line-2","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6029.0,"shares_display":"6,029","price_per_share":3.6809,"price_display":"3.68","price_state":"stated","total_value":22192.1461,"total_display":"22,192.15","total_whole":"22,192","shares_owned_after":26325.0,"shares_owned_after_display":"26,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-08","scope":"insider"},{"id":8622925,"accession":"0001104659-23-069421","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-069421","line_url":"/filing/0001104659-23-069421#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4068.0,"shares_display":"4,068","price_per_share":3.6294,"price_display":"3.63","price_state":"stated","total_value":14764.3992,"total_display":"14,764.40","total_whole":"14,764","shares_owned_after":20296.0,"shares_owned_after_display":"20,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-08","scope":"insider"},{"id":6955616,"accession":"0001104659-22-062920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-062920","line_url":"/filing/0001104659-22-062920#line-1","is_derivative":false,"issuer_cik":"0001781983","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001781983","owner_cik":"0001789042","owner_name":"Seizinger Bernd R.","owner_display_name":"Seizinger Bernd R.","owner_url":"/insider/0001789042","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":35500.0,"total_display":"35,500.00","total_whole":"35,500","shares_owned_after":318580.0,"shares_owned_after_display":"318,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001129928","name":"ONCOLYTICS BIOTECH INC","url":"/issuer/0001129928","role":"Director","n_filings":2,"first_seen":"2026-01-20","last_seen":"2026-02-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Director","n_filings":4,"first_seen":"2022-05-19","last_seen":"2024-10-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000882361","name":"Aptose Biosciences Inc.","url":"/issuer/0000882361","role":"Director","n_filings":1,"first_seen":"2023-09-25","last_seen":"2023-09-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001789042","retrieved_at":"2026-08-24T15:13:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}